SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-23-026760
Filing Date
2023-08-04
Accepted
2023-08-04 13:01:25
Documents
11

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 1875390
2 logo_001.jpg GRAPHIC 16865
3 form424b4_001.jpg GRAPHIC 40205
4 form424b4_002.jpg GRAPHIC 17600
5 form424b4_003.jpg GRAPHIC 94566
6 form424b4_004.jpg GRAPHIC 86671
7 form424b4_005.jpg GRAPHIC 6423
8 form424b4_006.jpg GRAPHIC 40205
9 form424b4_007.jpg GRAPHIC 94566
10 form424b4_008.jpg GRAPHIC 86671
11 form424b4_009.jpg GRAPHIC 149654
  Complete submission text file 0001493152-23-026760.txt   2749856
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: 424B4 | Act: 33 | File No.: 333-273024 | Film No.: 231143106
SIC: 2834 Pharmaceutical Preparations